Display options
Cite
Cotul EK, Zuo Q, Santaliz-Casiano A, et al. Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers. Cancers (Basel). 2020;12(9)doi: 10.3390/cancers12092397.
Cotul, E. K., Zuo, Q., Santaliz-Casiano, A., Imir, O. B., Mogol, A. N., Tunc, E., Duong, K., Lee, J. K., Ramesh, R., Odukoya, E., Kesavadas, M. P., Ziogaite, M., Smith, B. P., Mao, C., Shapiro, D. J., Park, B. H., Katzenellenbogen, B. S., Daly, D., Aranda, E., O'Neill, J. D., Walker, C., Landesman, Y., & Madak-Erdogan, Z. (2020). Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers. Cancers, 12(9), . https://doi.org/10.3390/cancers12092397
Cotul, Eylem Kulkoyluoglu, et al. "Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers." Cancers vol. 12,9 (2020). doi: https://doi.org/10.3390/cancers12092397
Cotul EK, Zuo Q, Santaliz-Casiano A, Imir OB, Mogol AN, Tunc E, Duong K, Lee JK, Ramesh R, Odukoya E, Kesavadas MP, Ziogaite M, Smith BP, Mao C, Shapiro DJ, Park BH, Katzenellenbogen BS, Daly D, Aranda E, O'Neill JD, Walker C, Landesman Y, Madak-Erdogan Z. Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers. Cancers (Basel). 2020 Aug 24;12(9). doi: 10.3390/cancers12092397. PMID: 32847042; PMCID: PMC7563274.
Copy Download .nbib Format: NLM
Share it on

Cancers (Basel). 2020 Aug 24;12(9). doi: 10.3390/cancers12092397.

Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers.

Cancers

Eylem Kulkoyluoglu Cotul, Qianying Zuo, Ashlie Santaliz-Casiano, Ozan Berk Imir, Ayca Nazli Mogol, Elif Tunc, Kevin Duong, Jenna Kathryn Lee, Rithva Ramesh, Elijah Odukoya, Mrinali P Kesavadas, Monika Ziogaite, Brandi Patrice Smith, Chengjian Mao, David J Shapiro, Ben Ho Park, Benita S Katzenellenbogen, Drew Daly, Evelyn Aranda, John D O'Neill, Christopher Walker, Yosef Landesman, Zeynep Madak-Erdogan

Affiliations

  1. Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
  2. Division of Nutritional Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
  3. Department of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
  4. Department of Human Development and Family Studies, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
  5. Department of Interdisciplinary Health Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
  6. Department of Informatics, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
  7. Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
  8. Cancer Center at Illinois, Urbana, IL 61801, USA.
  9. Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  10. Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
  11. Xylyx Bio, Inc., Brooklyn, NY 11226, USA.
  12. Karyopharm Therapeutics, Newton, MA 02459, USA.
  13. Beckman Institute for Advanced Science and Technology, Urbana, IL 61801, USA.
  14. Carl R. Woese Institute of Genomic Biology, Urbana, IL 61801, USA.

PMID: 32847042 PMCID: PMC7563274 DOI: 10.3390/cancers12092397

Abstract

The majority of breast cancer specific deaths in women with estrogen receptor positive (ER

Keywords: ESR1 mutant models; breast cancer; combination therapies; glutamine; metabolic rewiring; selinexor; tamoxifen

References

  1. Sci Adv. 2017 Aug 30;3(8):e1700521 - PubMed
  2. Diabetes. 2013 Apr;62(4):1297-307 - PubMed
  3. J Clin Oncol. 2016 Dec;34(34):4142-4150 - PubMed
  4. Nat Rev Clin Oncol. 2019 May;16(5):296-311 - PubMed
  5. J Clin Oncol. 2011 Jun 10;29(17):2301-4 - PubMed
  6. Ann Oncol. 2019 Dec 1;30(Suppl_10):x27-x42 - PubMed
  7. Trends Endocrinol Metab. 2019 Jan;30(1):25-38 - PubMed
  8. Cancer Res. 2019 May 15;79(10):2494-2510 - PubMed
  9. Nature. 2019 Mar;567(7748):399-404 - PubMed
  10. J Clin Oncol. 2014 Jul 20;32(21):2255-69 - PubMed
  11. J Clin Oncol. 2007 May 1;25(13):1683-90 - PubMed
  12. Bioinformatics. 2004 Jun 12;20(9):1453-4 - PubMed
  13. Bioinformatics. 2014 Aug 1;30(15):2114-20 - PubMed
  14. J Clin Endocrinol Metab. 2012 Dec;97(12):E2201-9 - PubMed
  15. J Mech Behav Biomed Mater. 2013 Jan;17:307-16 - PubMed
  16. Nucleic Acids Res. 2013 May 1;41(10):e108 - PubMed
  17. Cell Metab. 2017 Nov 7;26(5):778-787.e5 - PubMed
  18. Cell. 2015 Jul 30;162(3):540-51 - PubMed
  19. Nat Commun. 2019 May 7;10(1):1985 - PubMed
  20. Nucleic Acids Res. 2015 Apr 20;43(7):e47 - PubMed
  21. Front Oncol. 2018 Mar 23;8:75 - PubMed
  22. Breast Cancer Res. 2014 Sep 12;16(5):436 - PubMed
  23. Nat Biomed Eng. 2018 Dec;2(12):915-929 - PubMed
  24. J Clin Endocrinol Metab. 2014 Jul;99(7):E1191-8 - PubMed
  25. Ann Appl Stat. 2016 Jun;10(2):946-963 - PubMed
  26. J Mol Biol. 2005 Apr 15;347(5):921-34 - PubMed
  27. Steroids. 2016 Oct;114:41-47 - PubMed
  28. N Engl J Med. 2017 Nov 9;377(19):1836-1846 - PubMed
  29. Endocr Rev. 2010 Apr;31(2):194-223 - PubMed
  30. Cancer Discov. 2012 May;2(5):401-4 - PubMed
  31. Cancer Metab. 2013 Dec 05;1(1):22 - PubMed
  32. Nat Commun. 2017 Jun 27;8:15916 - PubMed
  33. Bioinformatics. 2010 Jan 1;26(1):139-40 - PubMed
  34. Breast Cancer Res Treat. 2015 Jan;149(1):69-79 - PubMed
  35. Mol Cell. 2018 Feb 15;69(4):581-593.e7 - PubMed
  36. Cell. 2017 Mar 23;169(1):148-160.e15 - PubMed
  37. J Clin Oncol. 2016 Sep 1;34(25):3069-103 - PubMed
  38. Semin Oncol. 2004 Feb;31(1 Suppl 3):28-38 - PubMed
  39. J Clin Oncol. 2016 Sep 10;34(26):3166-74 - PubMed
  40. Mol Endocrinol. 2016 Oct;30(10):1029-1045 - PubMed
  41. Cancer Cell. 2015 Jan 12;27(1):97-108 - PubMed
  42. Genes (Basel). 2018 Jan 22;9(1): - PubMed
  43. Nucleic Acids Res. 2018 Jul 2;46(W1):W486-W494 - PubMed
  44. Bioinformatics. 2013 Jan 1;29(1):15-21 - PubMed
  45. Breast Cancer Res Treat. 2020 Jun;181(2):297-307 - PubMed
  46. Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761 - PubMed
  47. Breast Cancer Res. 2011 Aug 12;13(4):215 - PubMed
  48. Cancers (Basel). 2019 Apr 04;11(4): - PubMed
  49. Nature. 2013 Apr 4;496(7443):101-5 - PubMed
  50. Nat Rev Cancer. 2016 Oct;16(10):619-34 - PubMed
  51. Sci Signal. 2013 Apr 02;6(269):pl1 - PubMed
  52. Hepatology. 2008 Apr;47(4):1394-400 - PubMed
  53. J Biol Chem. 2000 May 26;275(21):16302-8 - PubMed
  54. Onco Targets Ther. 2016 Jun 30;9:3963-73 - PubMed
  55. Mol Cancer Res. 2014 May;12(5):714-27 - PubMed
  56. Neoplasia. 2004 Jan-Feb;6(1):1-6 - PubMed
  57. Nat Cell Biol. 2014 Oct;16(10):992-1003, 1-15 - PubMed
  58. Nat Rev Cancer. 2017 May;17(5):302-317 - PubMed
  59. Nature. 2012 Apr 18;486(7403):346-52 - PubMed
  60. J Clin Oncol. 2016 Dec;34(34):4094-4101 - PubMed

Publication Types

Grant support